Issue Special Issue 2/2011
Observational trials in ADHD – the Observation of Safety and Effectiveness of EquasymXL® in Routine Care (OBSEER) study
Content (7 Articles)
Open Access
Supplement
Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence
Aribert Rothenberger, Manfred Döpfner
Open Access
Supplement
An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety
Manfred Döpfner, Anja Görtz-Dorten, Dieter Breuer, Aribert Rothenberger
Open Access
Supplement
An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence
Aribert Rothenberger, Andreas Becker, Dieter Breuer, Manfred Döpfner
Open Access
Supplement
Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD
Andreas Becker, Veit Roessner, Dieter Breuer, Manfred Döpfner, Aribert Rothenberger
Open Access
Supplement
An observational study of once-daily modified-release methylphenidate in ADHD: the effect of previous treatment on ADHD symptoms, other externalising symptoms and quality-of-life outcomes
Manfred Döpfner, Dieter Breuer, Daniel Walter, Aribert Rothenberger
Open Access
Supplement
Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
Dieter Breuer, Anja Görtz-Dorten, Aribert Rothenberger, Manfred Döpfner
Open Access
Supplement
What contributes to patient and parent satisfaction with medication in the treatment of children with ADHD? A report on the development of a new rating scale
Anja Görtz-Dorten, Dieter Breuer, Christopher Hautmann, Aribert Rothenberger, Manfred Döpfner